| scholarly article | Q13442814 |
| P2093 | author name string | Katherine M Dains | |
| Margaret Wilson | |||
| Delia Dempsey | |||
| Neal L Benowitz | |||
| Peyton Jacob | |||
| P2860 | cites work | Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study | Q24540484 |
| The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire | Q29615435 | ||
| Determination of phenolic metabolites of polycyclic aromatic hydrocarbons in human urine as their pentafluorobenzyl ether derivatives using liquid chromatography-tandem mass spectrometry | Q33436429 | ||
| Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites | Q33839242 | ||
| Tobacco carcinogens, their biomarkers and tobacco-induced cancer | Q33973290 | ||
| Time to first cigarette after waking predicts cotinine levels | Q34187411 | ||
| Urine menthol as a biomarker of mentholated cigarette smoking | Q34422437 | ||
| Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry | Q35198490 | ||
| A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers | Q36441730 | ||
| Racial/Ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25 to 44 years | Q36995925 | ||
| Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers | Q37149026 | ||
| Effects of menthol on tobacco smoke exposure, nicotine dependence, and NNAL glucuronidation | Q37178887 | ||
| Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers | Q37246043 | ||
| Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer | Q37426846 | ||
| Utility and relationships of biomarkers of smoking in African-American light smokers. | Q37470700 | ||
| Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers | Q42629778 | ||
| Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers | Q43287620 | ||
| Factors associated with discrepancies between self-reports on cigarette smoking and measured serum cotinine levels among persons aged 17 years or older: Third National Health and Nutrition Examination Survey, 1988-1994. | Q43570657 | ||
| The influence of gender, race, and menthol content on tobacco exposure measures | Q44070462 | ||
| Race differences in nicotine dependence in the Collaborative Genetic study of Nicotine Dependence (COGEND). | Q44509002 | ||
| Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. | Q44588389 | ||
| Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity | Q44960529 | ||
| Cotinine concentration in smokers from different countries: relationship with amount smoked and cigarette type | Q45111557 | ||
| Smokers of menthol and nonmenthol cigarettes exhibit similar levels of biomarkers of smoke exposure | Q46135155 | ||
| Ethnic and racial differences in the smoking-related risk of lung cancer | Q46138958 | ||
| Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine | Q46380339 | ||
| Relationship between menthol cigarettes and smoking cessation among African American light smokers | Q46384406 | ||
| Comparison of smoking-related risk factors among black and white males | Q46474278 | ||
| Effect of delivered dosage of cigarette smoke toxins on the levels of urinary biomarkers of exposure | Q46800885 | ||
| Shorter time to first cigarette of the day in menthol adolescent cigarette smokers | Q46816316 | ||
| Relationships between cigarette consumption and biomarkers of tobacco toxin exposure | Q46859319 | ||
| The association of a tobacco-specific biomarker and cigarette consumption and its dependence on host characteristics. | Q52291886 | ||
| Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels. | Q52861271 | ||
| Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991 | Q64132888 | ||
| Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans | Q67962065 | ||
| Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine | Q70863857 | ||
| Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids | Q71542539 | ||
| Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers | Q73794050 | ||
| Nicotine metabolism and intake in black and white smokers | Q74788995 | ||
| Tobacco use among U.S. racial/ethnic minority groups--African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, Hispanics. A Report of the Surgeon General. Executive summary | Q77449741 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nicotine | Q12144 |
| P304 | page(s) | 772-783 | |
| P577 | publication date | 2011-05-05 | |
| P1433 | published in | Nicotine and Tobacco Research | Q15762854 |
| P1476 | title | Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure | |
| P478 | volume | 13 |
| Q34452819 | 1,3-Butadiene exposure and metabolism among Japanese American, Native Hawaiian, and White smokers |
| Q88937995 | A Comparison of Direct and Indirect Analytical Approaches to Measuring Total Nicotine Equivalents in Urine |
| Q36757788 | A clinical trial to examine disparities in quitting between African-American and White adult smokers: Design, accrual, and baseline characteristics |
| Q36499756 | Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco-specific nitrosamine exposure and lower tobacco-specific nitrosamine bioactivation |
| Q35904621 | Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011-2012. |
| Q55500029 | Assessment of the abuse liability of three menthol Vuse Solo electronic cigarettes relative to combustible cigarettes and nicotine gum. |
| Q45361480 | Assigning dose of nicotine gum by time to first cigarette |
| Q33953232 | Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers |
| Q21131066 | Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease |
| Q34425646 | Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide |
| Q29248704 | Biomarkers of Tobacco Exposure: Summary of an FDA-sponsored Public Workshop |
| Q52306926 | Biomarkers of tobacco smoke exposure in racial/ethnic groups at high risk for lung cancer. |
| Q34918092 | CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations |
| Q35044263 | Combined analysis of the tobacco metabolites cotinine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine |
| Q37056893 | Comparison of Puff Volume With Cigarettes per Day in Predicting Nicotine Uptake Among Daily Smokers |
| Q37705535 | Cotinine and tobacco-specific carcinogen exposure among nondaily smokers in a multiethnic sample. |
| Q37719058 | Determination of tobacco smoke exposure by plasma cotinine levels in infants and children attending urban public hospital clinics |
| Q28396981 | Different profiles of carcinogen exposure in Chinese compared with US cigarette smokers |
| Q36173006 | Diurnal Evening Type is Associated with Current Smoking, Nicotine Dependence and Nicotine Intake in the Population Based National FINRISK 2007 Study |
| Q35855468 | Do Lung Cancer Eligibility Criteria Align with Risk among Blacks and Hispanics? |
| Q36787807 | Does COPD risk vary by ethnicity? A retrospective cross-sectional study |
| Q36078482 | Effect of menthol on nicotine pharmacokinetics in rats after cigarette smoke inhalation |
| Q91644869 | Effects of Nicotine Metabolic Rate on Withdrawal Symptoms and Response to Cigarette Smoking After Abstinence |
| Q36499803 | Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African Americans |
| Q46416161 | Estimations and predictors of non-compliance in switchers to reduced nicotine content cigarettes. |
| Q40067228 | Ethnic differences in smoking intensity and COPD risk: an observational study in primary care |
| Q38950808 | Examination of the Involvement of Cholinergic-Associated Genes in Nicotine Behaviors in European and African Americans |
| Q35899013 | Exposure and kinetics of polycyclic aromatic hydrocarbons (PAHs) in cigarette smokers. |
| Q36239226 | Exposure to nicotine and carcinogens among Southwestern Alaskan Native cigarette smokers and smokeless tobacco users |
| Q36645057 | Gene by Environment Investigation of Incident Lung Cancer Risk in African-Americans |
| Q28383750 | Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population |
| Q36001590 | Genome-wide meta-analyses of smoking behaviors in African Americans |
| Q49287792 | Impact of Smoking Ban on Passive Smoke Exposure in Pregnant Non-Smokers in the Southeastern United States |
| Q46327891 | Intent to quit, quit attempts, and perceived health risk reduction among African American, Latino, and White nondaily and daily smokers in the United States |
| Q53177073 | Lung Cancer Health Disparities. |
| Q36652289 | Motivations for genetic testing for lung cancer risk among young smokers |
| Q64112276 | Multi-ancestry genome-wide gene-smoking interaction study of 387,272 individuals identifies new loci associated with serum lipids |
| Q43581266 | NNAL exposure by race and menthol cigarette use among U.S. smokers |
| Q36870991 | Nicotine Metabolism in Young Adult Daily Menthol and Nonmenthol Smokers |
| Q33719341 | Nicotine and carcinogen exposure after water pipe smoking in hookah bars |
| Q35535816 | Nicotine, carbon monoxide, and carcinogen exposure after a single use of a water pipe. |
| Q37039384 | Not so Cool? Menthol's discovered actions on the nicotinic receptor and its implications for nicotine addiction |
| Q50656025 | One cigarette is one too many: evaluating a light smoker-targeted media campaign. |
| Q36589155 | Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling |
| Q38345693 | Pharmacogenetics of nicotine and associated smoking behaviors |
| Q52618061 | Protocol to assess the impact of tobacco-induced volatile organic compounds on cardiovascular risk in a cross- sectional cohort: Cardiovascular Injury due to Tobacco Use study. |
| Q33459509 | Quantitative analysis of five tobacco-specific N-nitrosamines in urine by liquid chromatography-atmospheric pressure ionization tandem mass spectrometry |
| Q39765572 | Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking. |
| Q36556906 | Racial differences in the relationship between tobacco dependence and nicotine and carcinogen exposure |
| Q36974530 | Racial differences in the relationship between tobacco, alcohol, and squamous cell carcinoma of the head and neck |
| Q88673438 | Racial differences in the relationship between tobacco, alcohol, and the risk of head and neck cancer: pooled analysis of US studies in the INHANCE Consortium |
| Q90439934 | Role of l- and d-Menthol in the Glucuronidation and Detoxification of the Major Lung Carcinogen, NNAL |
| Q89093597 | Secondhand smoke exposure and asthma outcomes among African-American and Latino children with asthma |
| Q35883271 | Self-reported Tobacco use does not correlate with carcinogen exposure in smokers with head and neck cancer |
| Q37597408 | Smoking and prostate cancer in a multi-ethnic cohort |
| Q36963394 | The Influence of Puff Characteristics, Nicotine Dependence, and Rate of Nicotine Metabolism on Daily Nicotine Exposure in African American Smokers |
| Q24595571 | The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex |
| Q38607385 | Tobacco toxicant exposure in cigarette smokers who use or do not use other tobacco products |
| Q104257661 | Transferability Of Ancestry-Specific And Cross-Ancestry CYP2A6 Activity Genetic Risk Scores In African And European Populations |
| Q34964392 | UGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers |
| Q36963678 | Urinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study |
| Q64231984 | Use of a Cross-Sectional Survey in the Adult Population to Characterize Persons at High-Risk for Chronic Obstructive Pulmonary Disease |
| Q35164670 | Variation in levels of the lung carcinogen NNAL and its glucuronides in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer |
| Q34926339 | Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake. |
| Q33362776 | Why We Must Continue to Investigate Menthol's Role in the African American Smoking Paradox. |
Search more.